Products
Tools
Education
$0.76
$0.71
$3.61
$0.72
$86.2M
-76.53%
This is a preview of the full version of Prosperse
The hepatic tumor market is driven by the increasing incidence of liver cancer, advancements in treatment options, and the growing emphasis on personalized medicine and combination therapies. The pipeline comprises 75+ companies working on 75+ pipeline therapies, with several promising candidates in...
Delveinsight
Jul 30, 2024
Date: Oct 25, 2024
Date: Oct 24, 2024